Compare NIO Inc. (NIO) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NIO Inc. vs Zoetis Inc — how do they compare? NIO Inc. trades at $3.58 (market cap $8.62B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 3.5× NIO Inc.'s market cap, and Zoetis Inc pays a 2.9% dividend while NIO Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold NIO Inc. for 81 Days and Zoetis Inc for 70 Days on average.
| NIO | ZTS | |
|---|---|---|
Market Cap | $8.62B | $30.20B |
Volume | 39,648,517 | 6,175,327 |
Sector | Consumer Cyclical | Health |
52-Week High | $7.42 | $147.53 |
52-Week Low | $3.37 | $69.09 |
Typical Hold Time | 81 Days | 70 Days |
Enterprise Value | $6.52B | $37.76B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NIO trades at $3.41, down 3.67% today and near its 52-week low of $3.38. The stock shows bearish technical signals with negative moving averages, though recent quarterly earnings have consistently beaten expectations. Revenue growth remains strong at $87.49 billion for 2025, but profitability challenges persist with a net loss of $15.57 billion. The recent Geely battery-swap partnership provides strategic expansion potential while raising questions about near-term profitability.
NIO presents a high-risk opportunity with significant upside potential given the $6.23 consensus price target, but faces substantial execution risks in China's competitive EV market. While analyst sentiment leans bullish with 50% buy ratings, investors must weigh strong revenue growth against persistent losses and negative cash flow trends before considering position entry.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NIO Inc.
NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.
Read more on NIO →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
